The U.S. Food and Drug Administration (FDA) is extending for 60 days the comment period for the draft Environmental Assessment (EA) and preliminary Finding of No Significant Impact (FONSI) pertaining to AquaBounty Technologies’ application for AquAdvantage Salmon.
IFT Daily News
Leave a Comment